Correction: MAPRE2 is associated with macrophage-enriched innate immune dysregulation and malignant phenotypes in hepatocellular carcinoma - Poll - MDSpire

Correction: MAPRE2 is associated with macrophage-enriched innate immune dysregulation and malignant phenotypes in hepatocellular carcinoma

  • By

  • Xiuqin An

  • Yanfang Gao

  • Shangyumeng Zhao

  • Wei He

  • Xinda Yang

  • Yujie Wu

  • Jihao Li

  • Runxi Yi

  • Yue Han

  • Mingxuan Li

  • Qiusheng Li

  • Ting Yang

  • June 17, 2026

  • 0 min

Share

Original Source(s)

Correction: MAPRE2 is associated with macrophage-enriched innate immune dysregulation and malignant phenotypes in hepatocellular carcinoma

  • by Xiuqin An, Yanfang Gao, Shangyumeng Zhao, Wei He, Xinda Yang, Yujie Wu, Jihao Li, Runxi Yi, Yue Han, Mingxuan Li, Qiusheng Li, Ting Yang

  • June 17, 2026

Related Content

Publisher Correction: Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligence

2026 AACR Renal Cell Carcinoma Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the renal cell carcinoma clinical updates you need to know from AACR 2026.

  • June 17, 2026

  • 1 min
Access to Specialty Cancer Care and Plan Disenrollment Among Medicare Beneficiaries